1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. COMPASS THERAPEUTICS INC

Compass Therapeutics Inc

XNAS: CMPX

Download real time

2.26 -0.05 (-2.16%)

44.61% Fall from 52W High

675.2K XNAS Volume

XNAS 19 Mar, 2025 4:00 PM (EDT)

Watchlist

Portfolio

Share
10S
10W
5O
0T
312.5

Market Cap

Below industry Median
-6.3

PE TTM

Negative PE TTM
0.4

PEG TTM

PEG TTM is less than 1
2.5

Price to Book

Below industry Median
0.6

Beta 1Year

Very Low volatility
Board Meeting
The next board meeting for Compass Therapeutics Inc is on 21 Mar 2025 for the purpose of Compass Therapeutics Inc Fourth Quarter Earnings Results for 2024 See details


Insider Trading disclosures for Compass Therapeutics Inc

The latest disclosure was made by Jonathan Anderman in Compass Therapeutics Inc where a trade of 280,000 Stock Option (Right to Buy) done was reported to US exchanges on Feb. 11, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Jonathan Anderman Sr VP, Gen Counsel & Corp Sec Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Feb 2025 280,000 280,000 - - Stock Option (Right to Buy)
James P. Boylan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Feb 2025 40,000 40,000 - - Stock Option (Right to Buy)
Philip J. Ferneau Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Feb 2025 40,000 40,000 - - Stock Option (Right to Buy)
Barry Shin CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Feb 2025 250,000 250,000 - - Stock Option (Right to Buy)
Thomas J. Schuetz Director, CHIEF EXECUTIVE OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Feb 2025 1,500,000 1,500,000 - - Stock Option (Right to Buy)
Neil Lerner SVP, CAO Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Feb 2025 200,000 200,000 - - Stock Option (Right to Buy)
Mary Ann Gray Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Feb 2025 40,000 40,000 - - Stock Option (Right to Buy)
Richard S. Lindahl Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Feb 2025 40,000 40,000 - - Stock Option (Right to Buy)
Ellen V. Chiniara Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Feb 2025 40,000 40,000 - - Stock Option (Right to Buy)
Carl L. Gordon Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Feb 2025 40,000 40,000 - - Stock Option (Right to Buy)
Thomas J. Schuetz Director, CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.50 per share. 08 Feb 2025 41,687 6,470,825 - 3.5 145,905 Common Stock
Thomas J. Schuetz Director, CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.86 per share. 09 Jan 2025 58,054 6,512,512 - 1.9 107,980 Common Stock
Barry Shin CFO Grant, award, or other acquisition of securities at price $ 1.65 per share. 09 Dec 2024 400,000 400,000 - 1.7 660,000 Common Stock
Barry Shin CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Dec 2024 400,000 400,000 - - Stock Option (Right to Buy)
Jonathan Anderman Sr VP, Gen Counsel & Corp Sec Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Aug 2024 300,000 300,000 - - Stock Option (Right to Buy)
James P. Boylan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Mar 2024 40,000 40,000 - - Stock Option (Right to Buy)
Richard S. Lindahl Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Feb 2024 40,000 40,000 - - Stock Option (Right to Buy)
Chiniara Ellen Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Feb 2024 40,000 40,000 - - Stock Option (Right to Buy)
Ferneau Phil Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Feb 2024 40,000 40,000 - - Stock Option (Right to Buy)
Ann Gray Mary Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Feb 2024 40,000 40,000 - - Stock Option (Right to Buy)
Gordon L. Carl Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Feb 2024 40,000 40,000 - - Stock Option (Right to Buy)
J. Thomas Schuetz Director, PRESIDENT Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.45 per share. 08 Feb 2024 44,782 6,570,566 - 1.5 64,934 Common Stock
Bisker-Leib Vered Director, CHIEF EXECUTIVE OFFICER Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.45 per share. 08 Feb 2024 49,198 3,124,426 - 1.4 71,337 Common Stock
Bisker-Leib Vered Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jan 2024 1,753,125 1,753,125 - - Stock Option (Right to Buy)
J. Schuetz Thomas Director, President of R&D Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jan 2024 637,500 637,500 - - Stock Option (Right to Buy)
Schuetz Thomas J. Director, President of R&D Grant, award, or other acquisition of securities at price $ 1.93 per share. 09 Jan 2024 637,500 6,615,348 - 1.9 1,230,375 Common Stock
Vered Bisker-Leib Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 1.93 per share. 09 Jan 2024 1,753,125 3,173,624 - 1.9 3,383,531 Common Stock
Thomas J. Schuetz Director, CHIEF EXECUTIVE OFFICER Purchase of securities on an exchange or from another person at price $ 3.37 per share. 10 Mar 2023 10,000 6,021,873 - 3.4 33,700 Common Stock
Thomas J. Schuetz Director, CHIEF EXECUTIVE OFFICER Purchase of securities on an exchange or from another person at price $ 3.98 per share. 27 Feb 2023 20,000 6,011,873 - 4.0 79,600 Common Stock
Thomas J. Schuetz Director, CHIEF EXECUTIVE OFFICER Purchase of securities on an exchange or from another person at price $ 3.86 per share. 15 Feb 2023 20,000 5,991,873 - 3.9 77,200 Common Stock
Phil Ferneau Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2023 50,000 50,000 - - Stock Option (Right to Buy)
Vered Bisker-Leib Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2023 400,000 1,484,914 - 0 Common Stock
Vered Bisker-Leib Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2023 600,000 600,000 - - Stock Option (Right to Buy)
Thomas J. Schuetz Director, CHIEF EXECUTIVE OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2023 500,000 5,971,873 - 0 Common Stock
Thomas J. Schuetz Director, CHIEF EXECUTIVE OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2023 700,000 700,000 - - Stock Option (Right to Buy)
Mary Ann Gray Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2023 40,000 40,000 - - Stock Option (Right to Buy)
David M. Wurzer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2023 50,000 50,000 - - Stock Option (Right to Buy)
Ellen Chiniara Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2023 40,000 40,000 - - Stock Option (Right to Buy)
Carl L. Gordon Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2023 60,000 60,000 - - Stock Option (Right to Buy)
Thomas J. Schuetz Director, CHIEF EXECUTIVE OFFICER Purchase of securities on an exchange or from another person at price $ 4.05 per share. 31 Jan 2023 20,000 5,471,873 - 4.1 81,000 Common Stock
Thomas J. Schuetz Director, CHIEF EXECUTIVE OFFICER Purchase of securities on an exchange or from another person at price $ 4.19 per share. 24 Jan 2023 20,000 5,451,873 - 4.2 83,800 Common Stock
Vered Bisker-Leib Chief Operating Officer Sale of securities on an exchange or to another person at price $ 4.40 per share. 18 Nov 2022 6,226 1,107,175 - 4.4 27,394 Common Stock
Vered Bisker-Leib Chief Operating Officer Sale of securities on an exchange or to another person at price $ 4.34 per share. 18 Nov 2022 16,035 1,084,914 - 4.3 69,592 Common Stock
Carl L. Gordon Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 3.21 per share. 08 Nov 2022 402,000 15,219,994 - 3.2 1,290,420 Common Stock
Thomas J. Schuetz Director, CHIEF EXECUTIVE OFFICER Purchase of securities on an exchange or from another person at price $ 2.32 per share. 28 Sep 2022 10,000 5,431,873 - 2.3 23,200 Common Stock
Thomas J. Schuetz Director, CHIEF EXECUTIVE OFFICER Purchase of securities on an exchange or from another person at price $ 2.27 per share. 26 Sep 2022 15,000 5,421,873 - 2.3 34,050 Common Stock
Thomas J. Schuetz Director, CHIEF EXECUTIVE OFFICER Purchase of securities on an exchange or from another person at price $ 3.03 per share. 07 Sep 2022 15,000 5,406,873 - 3.0 45,450 Common Stock
Thomas J. Schuetz Director, CHIEF EXECUTIVE OFFICER Purchase of securities on an exchange or from another person at price $ 2.83 per share. 01 Sep 2022 15,000 5,391,873 - 2.8 42,450 Common Stock
Thomas J. Schuetz Director, CHIEF EXECUTIVE OFFICER Purchase of securities on an exchange or from another person at price $ 3.05 per share. 17 Aug 2022 15,000 5,376,873 - 3.1 45,750 Common Stock
Thomas J. Schuetz Director, CHIEF EXECUTIVE OFFICER Purchase of securities on an exchange or from another person at price $ 2.64 per share. 10 Aug 2022 15,000 5,361,873 - 2.6 39,600 Common Stock
Thomas J. Schuetz Director, CHIEF EXECUTIVE OFFICER Purchase of securities on an exchange or from another person at price $ 2.58 per share. 01 Aug 2022 15,000 5,346,873 - 2.6 38,700 Common Stock
Thomas J. Schuetz Director, CHIEF EXECUTIVE OFFICER Purchase of securities on an exchange or from another person at price $ 2.80 per share. 21 Jun 2022 20,000 5,331,873 - 2.8 56,000 Common Stock
Thomas J. Schuetz Director, CHIEF EXECUTIVE OFFICER Purchase of securities on an exchange or from another person at price $ 2.34 per share. 16 Jun 2022 20,000 5,311,873 - 2.3 46,800 Common Stock
Thomas J. Schuetz Director, CHIEF EXECUTIVE OFFICER Purchase of securities on an exchange or from another person at price $ 2.29 per share. 13 Jun 2022 30,000 5,291,873 - 2.3 68,700 Common Stock
Thomas J. Schuetz Director, CHIEF EXECUTIVE OFFICER Purchase of securities on an exchange or from another person at price $ 2.83 per share. 06 Jun 2022 30,000 5,261,873 - 2.8 84,900 Common Stock
Thomas J. Schuetz Director, CHIEF EXECUTIVE OFFICER Purchase of securities on an exchange or from another person at price $ 3.03 per share. 01 Jun 2022 20,000 5,231,873 - 3.0 60,600 Common Stock
Thomas J. Schuetz Director, CHIEF EXECUTIVE OFFICER Purchase of securities on an exchange or from another person at price $ 3.04 per share. 26 May 2022 20,000 5,211,873 - 3.0 60,800 Common Stock
Thomas J. Schuetz Director, CHIEF EXECUTIVE OFFICER Purchase of securities on an exchange or from another person at price $ 2.72 per share. 23 May 2022 18,355 5,191,873 - 2.7 49,926 Common Stock
Thomas J. Schuetz Director, CHIEF EXECUTIVE OFFICER Purchase of securities on an exchange or from another person at price $ 2.47 per share. 17 May 2022 20,215 5,173,518 - 2.5 49,931 Common Stock
Carl L. Gordon Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 2.49 per share. 11 May 2022 30,722 14,817,994 - 2.5 76,498 Common Stock
Carl L. Gordon Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 2.35 per share. 11 May 2022 97,094 14,787,272 - 2.4 228,171 Common Stock
Carl L. Gordon Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 1.79 per share. 11 May 2022 64,700 14,690,178 - 1.8 115,813 Common Stock
Thomas J. Schuetz Director, CHIEF EXECUTIVE OFFICER Purchase of securities on an exchange or from another person at price $ 1.80 per share. 10 May 2022 27,836 5,153,303 - 1.8 50,105 Common Stock
Carl L. Gordon Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 1.60 per share. 06 May 2022 24,447 14,625,478 - 1.6 39,115 Common Stock
Carl L. Gordon Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 1.56 per share. 06 May 2022 90,712 14,601,031 - 1.6 141,511 Common Stock
Carl L. Gordon Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 1.63 per share. 06 May 2022 10,200 14,510,319 - 1.6 16,626 Common Stock
Mary Ann Gray Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Apr 2022 45,000 45,000 - - Stock Option (Right to Buy)
Ellen Chiniara Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Apr 2022 45,000 45,000 - - Stock Option (Right to Buy)
Susan Kalled Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Feb 2022 60,000 60,000 - - Stock Option (Right to Buy)
Phil Ferneau Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Feb 2022 30,000 30,000 - - Stock Option (Right to Buy)
Vered Bisker-Leib Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Feb 2022 500,000 500,000 - - Stock Option (Right to Buy)
Brett Kaplan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Feb 2022 30,000 30,000 - - Stock Option (Right to Buy)
Thomas J. Schuetz Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Feb 2022 700,000 700,000 - - Stock Option (Right to Buy)
Stephen P. Squinto Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Feb 2022 30,000 30,000 - - Stock Option (Right to Buy)
Carl L. Gordon Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Feb 2022 30,000 30,000 - - Stock Option (Right to Buy)
Thomas J. Schuetz Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Nov 2021 600,000 5,125,467 - 0 Common Stock
Vered Bisker-Leib Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Nov 2021 600,000 1,113,401 - 0 Common Stock
Carl L Gordon Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 3.50 per share. 04 Nov 2021 3,571,428 3,571,428 - 3.5 12,499,998 Common Stock
Carl L Gordon Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 3.50 per share. 04 Nov 2021 1,785,715 14,500,119 - 3.5 6,250,003 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters